Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next big pharmaceutical breakthrough. But he also faced a unique challenge ...

WEST LAFAYETTE, Ind. — Indiana Gov. Eric Holcomb has appointed David A. Ricks to the Purdue University Board of Trustees, effective Jan. 1, 2025, to July 1, 2027. Ricks is chair and CEO of Eli Lilly ...

Eli Lilly CEO Dave Ricks made $114 million in 2024, according to a new proxy statement to investors, putting him in the rare company of health care executives who have pulled in at least nine ...

The good news about donanemab, Eli Lilly’s Alzheimer’s drug, reached CEO Dave Ricks on July 2 as he was hiking in a remote part of Colorado. The pharmaceutical company had slogged for 35 years ...

Dave Ricks: Well, thanks for having me on, Diane. Great to be here. Of course, we're really proud of the success of the company, but I think of that is more like an outcome that is derived from ...

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, and obesity drugs.

The David Rubenstein ... Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat ...

David Ricks and Dr. Fatima Cody Stanford talk through the groundbreaking role of GLP-1 medications in transforming the treatment of obesity, and how they might reshape the future of health care ...

Dave Ricks: Well, thanks for having me on, Diane. Great to be here. Of course, we're really proud of the success of the company, but I think of that is more like an outcome that is derived from ...